연구성과로 돌아가기

2023 연구자 정보 (27 / 1135)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 ⓘ 교신저자 여부 ⓘ Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Hwang, Han Sung
(Hwang, HS) ⓘ 		Konkuk Univ, Sch Med, Med Ctr, Seoul, Seoul Tukpyolsi, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Impacts of tocolytics on maternal and neonatal glucose levels in women with gestational diabetes mellitus ⓘ SCIE ⓘ 1.1 OBSTETRICS & GYNECOLOGY ⓘ ⓘ
Im, S-A.
(Im, SA) ⓘ 		Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea ⓘ J-5620-2012
Im, Seock-Ah ⓘ
ⓘ 		[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Im, Seock-Ah
(Im, SA) ⓘ 		Seoul Natl Univ Hosp, Seoul, South Korea
Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Canc Res Inst, Seoul, South Korea
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea ⓘ 		J-5620-2012
Im, Seock-Ah ⓘ
ⓘ 		[JCR상위 1.1] T-DXd vs TPC in patients with HER2-low unresectable and/or metastatic BC in Asian subgroup: Results of DESTINY-Breast04
[JCR상위 3.5] Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial
[JCR상위 13.6] Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach ⓘ 		SCIE ⓘ 1.1 ONCOLOGY
MEDICINE, GENERAL & INTERNAL
GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY ⓘ 		x.pivot@icans.eu;
hkyang@snu.ac.kr; ⓘ
Iqbal, Rashid
(Iqbal, R) ⓘ 		Shenzhen Univ, Inst Adv Study, Shenzhen 518060, Guangdong, Peoples R China ⓘ G-4037-2018
IQBAL, RASHID ⓘ 		0000-0003-2953-6725
IQBAL, RASHID ⓘ 		[JCR상위 1.1] Exploration of metal organic frameworks and covalent organic frameworks for energy-related applications ⓘ SCIE ⓘ 1.1 CHEMISTRY, INORGANIC & NUCLEAR ⓘ Jiabao.yi@newcastle.edu.au;liang.qiao@uestc.edu.cn; ⓘ
Ismail, Pir Muhammad
(Ismail, PM) ⓘ 		Univ Elect Sci & Technol China, Sch Phys, Chengdu 610054, Peoples R China
Univ Elect Sci & Technol China, Yangtze Delta Reg Inst Huzhou, Huzhou 313001, Peoples R China ⓘ 		AGX-5266-2022
Ismail, Pir ⓘ
ⓘ 		[JCR상위 1.1] Exploration of metal organic frameworks and covalent organic frameworks for energy-related applications ⓘ SCIE ⓘ 1.1 CHEMISTRY, INORGANIC & NUCLEAR ⓘ Jiabao.yi@newcastle.edu.au;liang.qiao@uestc.edu.cn; ⓘ
Jacot, W.
(Jacot, W) ⓘ 		Inst Canc Montpellier, Med Oncol, Montpellier, France ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Subgroup analysis of patients (pts) with HER2-low metastatic breast cancer (mBC) with brain metastases (BMs) at baseline from DESTINY-Breast04, a randomized phase III study of trastuzumab deruxtecan (T-DXd) vs treatment of physician's choice (TPC) ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Jang, J.
(Jang, J) ⓘ 		Daegu Fatima Hosp, Fatima Res Inst, Daegu, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] CHEMOKINE RECEPTOR CXCR7 CONTRIBUTE TO THE INFLAMMATORY REACTION OF ARTICULAR CHONDROCYTE ⓘ SCIE ⓘ 1.1 ORTHOPEDICS;RHEUMATOLOGY ⓘ ⓘ
Jang, S. H.
(Jang, SH) ⓘ 		Hallym Univ, Dept Internal Med, Sacred Heart Hosp, Anyang, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Enhancing lung nodule discrimination with a novel cfDNA test: The cancer signature ensemble (CSE) approach ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Jung, Maeng-Joon
(Jung, MJ) ⓘ 		Kyungpook Natl Univ, Dept Chem, Daegu 41566, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] MOFs with bridging or terminal hydroxo ligands: Applications in adsorption, catalysis, and functionalization
[JCR상위 3.8] Identification and quantification of photodegradation products of disposed expanded polystyrene buoy used in aquaculture ⓘ 		SCIE ⓘ 1.1 CHEMISTRY, INORGANIC & NUCLEAR
ENVIRONMENTAL SCIENCES;MARINE & FRESHWATER BIOLOGY ⓘ 		sung@knu.ac.kr;
wjshim@kiost.ac.kr;sunghwank@knu.ac.kr; ⓘ
Kang, Y-K.
(Kang, YK) ⓘ 		제1저자 Univ Ulsan, Oncol Dept, Asan Med Ctr, Coll Med, Seoul, South Korea ⓘ ABL-4264-2022
Kang, Yoon-Koo ⓘ
ⓘ 		[JCR상위 1.1] Bemarituzumab (bema)+FOLFOX6 as first-line treatment in patients with FGFR2b overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer (G/ GEJC): East Asia subgroup of FIGHT final analysis ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Kelley, R. K.
(Kelley, RK) ⓘ 		UCSF Univ Calif San Francisco Parnassus Campus, Med Hematol Oncol, San Francisco, CA USA ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC): Updated efficacy and safety from KEYNOTE-966 ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Kim, G.
(Kim, G) ⓘ 		Daegu Fatima Hosp, Busan, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] CHEMOKINE RECEPTOR CXCR7 CONTRIBUTE TO THE INFLAMMATORY REACTION OF ARTICULAR CHONDROCYTE ⓘ SCIE ⓘ 1.1 ORTHOPEDICS;RHEUMATOLOGY ⓘ ⓘ
Kim, H-P.
(Kim, HP) ⓘ 		IMBdx Inc, Dept Res, Seoul, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Enhancing lung nodule discrimination with a novel cfDNA test: The cancer signature ensemble (CSE) approach ⓘ SCIE ⓘ 1.1 ONCOLOGY ⓘ ⓘ
Kim, Hee Sun
(Kim, HS) ⓘ 		Dongguk Univ, Grad Sch Med, Goyang, Kyonggi Do, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] Impacts of tocolytics on maternal and neonatal glucose levels in women with gestational diabetes mellitus ⓘ SCIE ⓘ 1.1 OBSTETRICS & GYNECOLOGY ⓘ ⓘ
Kim, Hyo-shin
(Kim, HS) ⓘ 		Kyungpook Natl Univ Hosp, Daegu, Taegu Jikhalsi, South Korea ⓘ
ⓘ
ⓘ 		[JCR상위 1.1] The expression of proteins associated with iron metabolism in the human placenta complicated with preeclampsia ⓘ SCIE ⓘ 1.1 OBSTETRICS & GYNECOLOGY ⓘ ⓘ
페이지 이동: